Anterogen.Co.,Ltd is a biotechnology company that specializes in stem cell therapeutics and nucleoside analogs, particularly the compound POM-L-BHDU. Anterogen.Co.,Ltd is developing oral-doseable compounds and has secured a patent in China for targeted inflammatory therapies. The company is collaborating with a foreign manufacturer to export its cell therapeutic products to Japan.
Headquarters
405 130 Digital-Ro, Geumcheon-Gu
Seoul; Seoul;
Postal Code: 08589
Contact Details: Purchase the Anterogen Co.,Ltd. report to view the information.
Website: http://www.anterogen.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service